Previous treatment with #adalimumab independently predicts lower #infliximab trough levels at the time of endoscopic remission in pediatric #Crohn disease patients. @crohnscolitisfdn.bsky.social
https://www.gastroenterologyadvisor.com/news/pediatric-crohn-disease-endoscopic-remission-infliximab/
https://www.gastroenterologyadvisor.com/news/pediatric-crohn-disease-endoscopic-remission-infliximab/
Prior Adalimumab Exposure Affects Infliximab Treatment in Pediatric Crohn Disease
Endoscopic remission in pediatric Crohn disease occurred at lower infliximab trough levels among patients with previous adalimumab exposure.
www.gastroenterologyadvisor.com
October 2, 2026 at 10:46 PM
Previous treatment with #adalimumab independently predicts lower #infliximab trough levels at the time of endoscopic remission in pediatric #Crohn disease patients. @crohnscolitisfdn.bsky.social
https://www.gastroenterologyadvisor.com/news/pediatric-crohn-disease-endoscopic-remission-infliximab/
https://www.gastroenterologyadvisor.com/news/pediatric-crohn-disease-endoscopic-remission-infliximab/
🛡️ Immunogenicity does not compromise outcomes with subcutaneous #infliximab
🔸Anti-drug antibodies (#ADAs) lowered drug levels but not 1-year efficacy or safety
🔸Treatment persistence remained similar regardless of ADA status
Find out more in this UEG Journal article:
👉 https://bit.ly/3UESgZp
🔸Anti-drug antibodies (#ADAs) lowered drug levels but not 1-year efficacy or safety
🔸Treatment persistence remained similar regardless of ADA status
Find out more in this UEG Journal article:
👉 https://bit.ly/3UESgZp
October 2, 2026 at 4:30 AM
🛡️ Immunogenicity does not compromise outcomes with subcutaneous #infliximab
🔸Anti-drug antibodies (#ADAs) lowered drug levels but not 1-year efficacy or safety
🔸Treatment persistence remained similar regardless of ADA status
Find out more in this UEG Journal article:
👉 https://bit.ly/3UESgZp
🔸Anti-drug antibodies (#ADAs) lowered drug levels but not 1-year efficacy or safety
🔸Treatment persistence remained similar regardless of ADA status
Find out more in this UEG Journal article:
👉 https://bit.ly/3UESgZp
From @aga-cgh.bsky.social 💊
#Upadacitinib and #infliximab provide the most rapid onset of symptom improvement among those with moderate to severe #UlcerativeColitis with no medical history of #BiologicTherapy. #GastroSky
@westernu.ca
@feinberg.northwestern.edu
@meduniwien.ac.at
#Upadacitinib and #infliximab provide the most rapid onset of symptom improvement among those with moderate to severe #UlcerativeColitis with no medical history of #BiologicTherapy. #GastroSky
@westernu.ca
@feinberg.northwestern.edu
@meduniwien.ac.at
Upadacitinib, Infliximab Produce Fastest Onset of Action in Biologic-Naive UC
Upadacitinib and infliximab produce the fastest symptom relief and highest post-induction clinical response rates in moderate to severe UC.
www.gastroenterologyadvisor.com
July 1, 2026 at 9:50 PM
From @aga-cgh.bsky.social 💊
#Upadacitinib and #infliximab provide the most rapid onset of symptom improvement among those with moderate to severe #UlcerativeColitis with no medical history of #BiologicTherapy. #GastroSky
@westernu.ca
@feinberg.northwestern.edu
@meduniwien.ac.at
#Upadacitinib and #infliximab provide the most rapid onset of symptom improvement among those with moderate to severe #UlcerativeColitis with no medical history of #BiologicTherapy. #GastroSky
@westernu.ca
@feinberg.northwestern.edu
@meduniwien.ac.at
- In a review of 23,458 patients exposed to adalimumab, the incidence rate of serious demyelinating disorders was ≤0.1 events per 100 person-years (Hamdan et al., 2024)
-The most frequently implicated TNF-α inhibitors in demyelinating events are #etanercept, #infliximab & #adalimumab
-The most frequently implicated TNF-α inhibitors in demyelinating events are #etanercept, #infliximab & #adalimumab
November 25, 2025 at 4:51 AM
- In a review of 23,458 patients exposed to adalimumab, the incidence rate of serious demyelinating disorders was ≤0.1 events per 100 person-years (Hamdan et al., 2024)
-The most frequently implicated TNF-α inhibitors in demyelinating events are #etanercept, #infliximab & #adalimumab
-The most frequently implicated TNF-α inhibitors in demyelinating events are #etanercept, #infliximab & #adalimumab
In the BIOGEAS Registry, demyelination was estimated to occur in 0.03–0.2% of patients, most frequently in those with RA/JIA , IBD, & in patients exposed to etanercept and #infliximab
In A review of 39,933 patients exposed to biologics found CNS #demyelinatingdiseases in 13 patients (0.03%)
In A review of 39,933 patients exposed to biologics found CNS #demyelinatingdiseases in 13 patients (0.03%)
November 25, 2025 at 4:49 AM
In the BIOGEAS Registry, demyelination was estimated to occur in 0.03–0.2% of patients, most frequently in those with RA/JIA , IBD, & in patients exposed to etanercept and #infliximab
In A review of 39,933 patients exposed to biologics found CNS #demyelinatingdiseases in 13 patients (0.03%)
In A review of 39,933 patients exposed to biologics found CNS #demyelinatingdiseases in 13 patients (0.03%)
August 28, 2025 at 6:06 PM
First Remsima injection booked 💉
No more infusions for me. At least not for the foreseeable future.
#Crohns #IBD #Infliximab
No more infusions for me. At least not for the foreseeable future.
#Crohns #IBD #Infliximab
August 7, 2025 at 5:01 PM
First Remsima injection booked 💉
No more infusions for me. At least not for the foreseeable future.
#Crohns #IBD #Infliximab
No more infusions for me. At least not for the foreseeable future.
#Crohns #IBD #Infliximab
As for my #Crohns, I’ll be switching from Renflexis to Remsima, a self injectable soon. Anyone have any experience with it?
#IBD #Infliximab
#IBD #Infliximab
July 28, 2025 at 12:29 AM
As for my #Crohns, I’ll be switching from Renflexis to Remsima, a self injectable soon. Anyone have any experience with it?
#IBD #Infliximab
#IBD #Infliximab
📌Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome
Induction therapy with #infliximab had a superior complete response rate at 22 weeks and fewer adverse events than induction with #cyclophosphamide
#behçet @nejm.org
evidence.nejm.org/doi/full/10....
Induction therapy with #infliximab had a superior complete response rate at 22 weeks and fewer adverse events than induction with #cyclophosphamide
#behçet @nejm.org
evidence.nejm.org/doi/full/10....
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome
Cyclophosphamide and infliximab are recommended as induction therapies for severe
Behçet’s syndrome. Whether infliximab is safer and more effective than cyclophosphamide
in treating severe Behçet’s...
evidence.nejm.org
February 4, 2025 at 8:56 PM
📌Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome
Induction therapy with #infliximab had a superior complete response rate at 22 weeks and fewer adverse events than induction with #cyclophosphamide
#behçet @nejm.org
evidence.nejm.org/doi/full/10....
Induction therapy with #infliximab had a superior complete response rate at 22 weeks and fewer adverse events than induction with #cyclophosphamide
#behçet @nejm.org
evidence.nejm.org/doi/full/10....
Meer weten: tinyurl.com/th8xssuv. Check ook: www.meldpuntmedicijnen.nl.
#biologicals #biosimilars #referentiemiddel #meldpuntmedicijnen #adalimumab #etanercept #infliximab #rituximab #trastuzumab #natalizumab #MS #JCvirustest #nocebo #ziekenhuis #zorgverleners
#biologicals #biosimilars #referentiemiddel #meldpuntmedicijnen #adalimumab #etanercept #infliximab #rituximab #trastuzumab #natalizumab #MS #JCvirustest #nocebo #ziekenhuis #zorgverleners
De overstap naar biosimilars: goedkoper, maar niet altijd probleemloos - DOQ
Hoewel biosimilars gelijkwaardig zijn aan hun referentiegeneesmiddel, reageren sommige patiënten anders op een biosimilar. Marjorie Nelissen licht toe hoe dit zit.
tinyurl.com
May 7, 2026 at 7:52 AM
I'm in the hospital receiving my regular #Infliximab infusion for #CrohnsDisease and #EltonJohn pops on the radio with #ImStillStanding. love it, it sums up the last 21 years managing my wee pal 🤣
youtu.be/ZHwVBirqD2s?...
youtu.be/ZHwVBirqD2s?...
Elton John - I'm Still Standing
YouTube video by EltonJohnVEVO
youtu.be
June 18, 2025 at 12:48 PM
I'm in the hospital receiving my regular #Infliximab infusion for #CrohnsDisease and #EltonJohn pops on the radio with #ImStillStanding. love it, it sums up the last 21 years managing my wee pal 🤣
youtu.be/ZHwVBirqD2s?...
youtu.be/ZHwVBirqD2s?...
what's the best thing to do when you're plugged in for your #Infliximab infusion? it's to listen to the current podcast from @popgays.bsky.social
linktr.ee/PGOACA?utm_s...
linktr.ee/PGOACA?utm_s...
February 21, 2025 at 1:31 PM
what's the best thing to do when you're plugged in for your #Infliximab infusion? it's to listen to the current podcast from @popgays.bsky.social
linktr.ee/PGOACA?utm_s...
linktr.ee/PGOACA?utm_s...
the best thing to do when you're plugged in for your next ##Infliximab infusion for #IDB is to listen to the latest episode of the @popgays.bsky.social podcast #RemixHeaven.
linktr.ee/PGOACA?utm_s...
linktr.ee/PGOACA?utm_s...
January 10, 2025 at 11:37 AM
the best thing to do when you're plugged in for your next ##Infliximab infusion for #IDB is to listen to the latest episode of the @popgays.bsky.social podcast #RemixHeaven.
linktr.ee/PGOACA?utm_s...
linktr.ee/PGOACA?utm_s...
the best thing to listen to when you're hooked up for your #Infliximab top-up is the current #podcast from the @popgays.bsky.social with #LadiesOfSoul
#Crohns #IBD
open.spotify.com/episode/4kE0...
#Crohns #IBD
open.spotify.com/episode/4kE0...
58.0 Ladies of Soul
Pop Gays Of A Certain Age · Episode
open.spotify.com
November 29, 2024 at 11:15 AM
the best thing to listen to when you're hooked up for your #Infliximab top-up is the current #podcast from the @popgays.bsky.social with #LadiesOfSoul
#Crohns #IBD
open.spotify.com/episode/4kE0...
#Crohns #IBD
open.spotify.com/episode/4kE0...
infusion day today, this little monkey #Crohns needs an extra boost this month with a top-up with #Infliximab 🤩
December 29, 2023 at 9:59 AM
infusion day today, this little monkey #Crohns needs an extra boost this month with a top-up with #Infliximab 🤩
🎧 Drug withdrawal in #IBD: a patient's perspective.
open.spotify.com/episode/3Tcf...
#crohns #crohnsdisease #ulcerativecolitis #inflammatoryboweldisease #infliximab
open.spotify.com/episode/3Tcf...
#crohns #crohnsdisease #ulcerativecolitis #inflammatoryboweldisease #infliximab
#19 Rachel reflects on staying in Crohn's remission, four years after stopping infliximab
open.spotify.com
October 26, 2025 at 9:17 AM
🎧 Drug withdrawal in #IBD: a patient's perspective.
open.spotify.com/episode/3Tcf...
#crohns #crohnsdisease #ulcerativecolitis #inflammatoryboweldisease #infliximab
open.spotify.com/episode/3Tcf...
#crohns #crohnsdisease #ulcerativecolitis #inflammatoryboweldisease #infliximab
#RemicadeDay once again
#theunworthy #augustinabazterrica #horror #horrorfan #horrornovel #tenderistheflesh #horrorfiction #crohns #fuckcrohns #autoimmune #IVtherapy #ivinfusion #infliximab
#theunworthy #augustinabazterrica #horror #horrorfan #horrornovel #tenderistheflesh #horrorfiction #crohns #fuckcrohns #autoimmune #IVtherapy #ivinfusion #infliximab
April 9, 2025 at 6:03 PM
Infliximab therapy for Crohn’s disease is linked to a high risk for IgAN, a study found. #infliximab #igan #iganephropathy #crohns #nephrology #nephsky www.docwirenews.com/post/case-st...
Case Studies Highlight Link Between Crohn’s Disease Treatment and IgAN | Docwire News
Infliximab therapy for Crohn’s disease is linked to a high risk for IgA nephropathy (IgAN), a study found.
www.docwirenews.com
June 25, 2025 at 4:31 PM
Infliximab therapy for Crohn’s disease is linked to a high risk for IgAN, a study found. #infliximab #igan #iganephropathy #crohns #nephrology #nephsky www.docwirenews.com/post/case-st...
#MedNews - Ten-year results of the LIR!C trial suggest that ileocecal resection offers a higher rate of long-term, therapy-free remission than #infliximab for patients with uncomplicated ileocecal #CrohnsDisease.
Full story 👉 buff.ly/tWuNGOQ
#GastroSky
Full story 👉 buff.ly/tWuNGOQ
#GastroSky
Early ileocecal resection offers long-term remission for some Crohn’s disease patients
Ten-year results of the LIR!C trial suggest that ileocecal resection offers a higher rate of long-term, therapy-free remission than infliximab for patients with uncomplicated ileocecal Crohn’s disease.
www.springermedicine.com
March 4, 2026 at 7:25 PM
#MedNews - Ten-year results of the LIR!C trial suggest that ileocecal resection offers a higher rate of long-term, therapy-free remission than #infliximab for patients with uncomplicated ileocecal #CrohnsDisease.
Full story 👉 buff.ly/tWuNGOQ
#GastroSky
Full story 👉 buff.ly/tWuNGOQ
#GastroSky
Morning lovelies😊
Going to play here for a while. The other sandpit is getting more vile by the second!
What's up w/ me:
In Sept I started #Infliximab Infusions& #Mounjaro. I was so ill/inflamed I was in full body crisis in danger of organ issues. On crutches 0 quality of life
Today QofL is 8/10
Going to play here for a while. The other sandpit is getting more vile by the second!
What's up w/ me:
In Sept I started #Infliximab Infusions& #Mounjaro. I was so ill/inflamed I was in full body crisis in danger of organ issues. On crutches 0 quality of life
Today QofL is 8/10
January 10, 2026 at 9:13 AM
Morning lovelies😊
Going to play here for a while. The other sandpit is getting more vile by the second!
What's up w/ me:
In Sept I started #Infliximab Infusions& #Mounjaro. I was so ill/inflamed I was in full body crisis in danger of organ issues. On crutches 0 quality of life
Today QofL is 8/10
Going to play here for a while. The other sandpit is getting more vile by the second!
What's up w/ me:
In Sept I started #Infliximab Infusions& #Mounjaro. I was so ill/inflamed I was in full body crisis in danger of organ issues. On crutches 0 quality of life
Today QofL is 8/10
#Infliximab for Grade III/IV #ICI #Nephritis Clinical and Translational Evidence
#VisualAbstract by Edgar V. Lerma 🇵🇭
https://www.kireports.org/article/S2468-0249(25)00662-X/fulltext
#VisualAbstract by Edgar V. Lerma 🇵🇭
https://www.kireports.org/article/S2468-0249(25)00662-X/fulltext
November 7, 2025 at 2:01 PM
#Infliximab for Grade III/IV #ICI #Nephritis Clinical and Translational Evidence
#VisualAbstract by Edgar V. Lerma 🇵🇭
https://www.kireports.org/article/S2468-0249(25)00662-X/fulltext
#VisualAbstract by Edgar V. Lerma 🇵🇭
https://www.kireports.org/article/S2468-0249(25)00662-X/fulltext
Letter to editor
Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab
#Serum #Sickness #Atraumatic #SplenicRupture #Infliximab #CirculatingImmuneComplexes
www.em-consulte.com/article/1743...
Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab
#Serum #Sickness #Atraumatic #SplenicRupture #Infliximab #CirculatingImmuneComplexes
www.em-consulte.com/article/1743...
Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab
Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab
www.em-consulte.com
May 26, 2025 at 6:03 AM
Letter to editor
Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab
#Serum #Sickness #Atraumatic #SplenicRupture #Infliximab #CirculatingImmuneComplexes
www.em-consulte.com/article/1743...
Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab
#Serum #Sickness #Atraumatic #SplenicRupture #Infliximab #CirculatingImmuneComplexes
www.em-consulte.com/article/1743...
Damn. Wish I hadn't had to break off from #Infliximab now. If the side effects get too much - already overweight with skin issues caused by #IBD - then I'll request we give #Infliximab a try again and risk #anaphylaxis
Thanks for the heads up.
Thanks for the heads up.
July 17, 2026 at 12:34 AM
Damn. Wish I hadn't had to break off from #Infliximab now. If the side effects get too much - already overweight with skin issues caused by #IBD - then I'll request we give #Infliximab a try again and risk #anaphylaxis
Thanks for the heads up.
Thanks for the heads up.